Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
Halucenex to get recently harvested initial batch of psilocybe cubensis
Optimi Head of Cultivation, Todd Henderson
Psilocybin Cubensis
VANCOUVER, British Columbia, Might 27, 2022 (World NEWSWIRE) — Optimi Health and fitness Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian corporation making all-natural, scalable, and available mushroom formulations for transformational human encounters, is delighted to announce that it has entered into a offer settlement with Halucenex Daily life Sciences Inc. (“Halucenex”), a wholly owned subsidiary of Creso Pharma of Australia (ASX: CPH). Halucenex is primarily based in Windsor, Nova Scotia and is a lifestyle sciences corporation focused on exploring novel psychedelic compounds, establishing and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets, and conducting scientific trials on the healthcare rewards of psychedelic drugs.
Additionally, Optimi needs to validate that the provide agreement pertains to the entirety of the Company’s recently harvested 1st batch of psilocybe cubensis mushrooms at its Princeton, British Columbia facility. The mushrooms will be equipped to Halucenex in the variety of total, dried mushroom fruiting bodies.
“This to start with provide arrangement, coming so quickly soon after our initial complete cultivation cycle, is a strong affirmation of our selection to pursue the advancement of natural, GMP psilocybin,” said Monthly bill Ciprick, CEO of Optimi. “From this initial proof-of-notion batch, our cultivation staff will go on to scale our operations to meet the calls for of the sector, domestically and internationally with licensed entities and for individual people within Canada in accordance to the terms of the Special Obtain Software.”
Halucenex CEO, Invoice Fleming, says the arrangement with Optimi is one particular each corporations will reward from.
“We’re really psyched to be transferring ahead on this provide agreement with the workforce at Optimi Wellness,” mentioned Fleming. “Among our major priorities in the enhancement of a psychedelic-assisted psychotherapeutic design for problems these kinds of as anxiousness and article-traumatic worry disorder has been to secure a risk-free, regular offer of GMP psilocybin.”
Authorized functions interested in buying Optimi psilocybin and useful mushroom goods need to send an e-mail to income@optimihealth.ca exactly where a member of the profits staff will answer inside 24 hrs.
ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)
Optimi Health and fitness Inc. is a homegrown, Canadian accomplishment tale generating and providing purely natural, EU-GMP grade psilocybin and functional mushrooms that aim on the overall health and wellness marketplaces. Crafted with the purpose to make scalable, purely natural mushroom formulations for transformational human encounters, the Company’s purpose is to be the amount just one dependable, compassionate provider of harmless, pure GMP grade psilocybin across the world. With a vertically integrated method, Optimi intends to cultivate, extract, method and distribute substantial quality practical and psychedelic mushroom products and solutions at its two services comprising a total of 20,000 square toes in Princeton, British Columbia.
To totally investigate the science of mushrooms, the Company has acquired a investigate exemption under Wellbeing Canada Food stuff and Drug Regulations (FDR) for the use of psilocybin and psilocin for scientific uses by using its wholly owned subsidiary Optimi Labs Inc. Optimi has also been granted a dealer’s license below Canada’s Narcotic Handle Regulations governing possession, distribution, sale, laboratory assessment of and investigation and enhancement of psilocybin and psilocin formulations. Optimi is committed to expert cultivation and high-quality output matter to and in accordance with the phrases of all applicable laws and governing regulations to make sure harmless, outstanding Canadian fungi output.
Optimi was lately granted an modification to its Dealer’s Licence by Wellness Canada, making it possible for the Enterprise to possess a quota of up to 5000kg of dried psilocybin mushrooms – the equivalent of 10kg of psilocybin – and 100g of psilocin.
ABOUT HALUCENEX
Halucenex operates a 6000 sq ft professional medical facility in Windsor, Nova Scotia with 6 treatment method rooms and a secure laboratory committed to doing psychedelic-assisted psychotherapy and clinical research. Halucenex intends to sustain regulate over all factors of the item enhancement process – mycological research, extraction technological innovation, and artificial formulation as well as drug shipping and delivery technologies, psychedelic-assisted psychotherapy and regulatory affairs.
Clinically, Halucenex is targeted on studying psilocybin, psilocybin-derivatives, and other psychedelic drugs for the needs of managing purchasers struggling from PTSD and anxiety employing its comprehensive psilocybin-assisted psychotherapy treatment model. Halucenex is committed to advancing the science about the use of psilocybin in psychedelic-assisted psychotherapy by:
For extra info or to request an interview, please make contact with:
Michael Kydd
Media & Stakeholder Relations Advisor
E-mail: michael@kyddergroup.com
Cellular phone: +1 (902) 880 6121
FORWARD‐LOOKING STATEMENTS
This information release contains forward‐looking statements and forward‐looking info within the meaning of Canadian securities laws (collectively, “forward‐looking statements”) that relate to Optimi’s recent expectations and sights of potential functions. Any statements that specific, or contain conversations as to, expectations, beliefs, designs, goals, assumptions or long run gatherings or performance (often, but not constantly, as a result of the use of words or phrases this sort of as “will most likely consequence,” “are expected to,” “expects,” “will keep on,” “is anticipated,” “anticipates,” “believes,” “estimated,” “intends,” “plans,” “forecast,” “projection,” “strategy,” “objective,” and “outlook”) are not historical information and may perhaps be forward‐looking statements and may well require estimates, assumptions and uncertainties which could bring about true outcomes or outcomes to differ materially from those people expressed in these forward‐looking statements. No assurance can be given that these anticipations will demonstrate to be appropriate and this sort of forward‐looking statements integrated in this news release should really not be unduly relied on. These statements talk only as of the day of this information launch. In distinct and without limitation, this information launch consists of forward‐ searching statements pertaining to activities proposed to be carried out under the Company’s dealer’s license and linked business enterprise connected to psilocybin and psilocin and Optimi’s options, aim and aims.
Forward‐looking statements are based mostly on a quantity of assumptions and are subject matter to a number of challenges and uncertainties, numerous of which are outside of Optimi’s management, which could bring about precise success and occasions to vary materially from these that are disclosed in or implied by this kind of forward‐looking statements. These types of challenges and uncertainties consist of, but are not constrained to, the impact and progression of the COVID‐19 pandemic and other variables set forth beneath “Forward‐Looking Statements” and “Risk Factors” in the Company’s Yearly details Kind dated January 12, 2022, and other ongoing disclosure filings available below Optimi’s profile at www.sedar.com. Optimi undertakes no obligation to update or revise any forward‐looking statements, regardless of whether as a result of new facts, future functions or otherwise, except as may be necessary by legislation. New factors emerge from time to time, and it is not possible for Optimi to predict all of them or assess the influence of just about every these component or the extent to which any component, or mixture of factors, may well induce results to vary materially from people contained in any forward‐looking statement.
Any forward‐looking statements contained in this news launch are expressly experienced in their entirety by this cautionary statement.
Pics accompanying this announcement are obtainable at
https://www.globenewswire.com/NewsRoom/AttachmentNg/b1df7352-0b4b-48e9-a3f1-950de89cd66a
https://www.globenewswire.com/NewsRoom/AttachmentNg/82589a86-5ae3-4399-b33e-5b4b9927bcb4
